Member Info for The-Hat

The results are known since Oct 2020.

Maybe waiting for Steve to be done or at least reach a much lower level?

Maybe their waiting for Steve to be done so they can release news and not have him sell into it.

If I'm in the US accumulating why should I care about the 3% rule????

Well said Brewsky.

We were always going to have to give something to Lilly, we are licencing from them. I think the payments are quite modest. It also allows us to sub-licence.

I could go on every pre-clinical pharma and AIM Share's message board and shout placing incoming, eventually I would be right on almost all of them. Wouldn't consider myself to be calling it right though. (Yes, I know HEMO is not on AIM)

It might be just a patent, what if it had been refused, would it have just been a refusal?

If there is to be an RNS, more than likely be an afternoon RNS. I think it was a bit tongue in cheek anyway.

Another popped up 1.5m in total. Hope so
17-Jun-21 13:15:07 30.00 253,033 Unknown* 29.50 30.50 75.91k O
17-Jun-21 13:15:07 30.00 253,033 Unknown* 29.50 30.50 75.91k O

17-Jun-21 12:47:59 30.00 493,935 Unknown* 29.50 30.50 148.18k O
17-Jun-21 12:47:52 30.00 506,065 Unknown* 29.50 30.50 151.82k O

I suspect it's being sold into massively, placing shares taking a profit, traders and some just exiting after averaging down and minimising losses. Just needs time to churn...agree, next year should be a much different place.

@PG From what I understand what is good for IBS-C is bad for IBS-D and vice versa for obvious reasons. So a correct diagnosis is vital or could make the situation worse. A lot of patients show both symptoms and therefor can't be diagnosed correctly or can't be prescribed anything.
So an effective single product that covers all, means a doctor only needs to diagnose IBS and not worry about C or D.
That's my understanding of it. Not a medical profession either.

My point is more for a HTO situation where Vlad is not a willing participant. Pre-clinical or even early clinical stage no company is going to touch them unless Vlad is a willing participant. How much of the IP is in his head, how much of the IP is currently protected??
Absolutely he could set-up HEMO2 and work from what he knows, yes it would be a set back but would just needs to make it a little better than what he sold and he would be good. I am not saying that is what would happen, just why a TO won't if Vlad doesn't want it, Veto or not.

Can't see a TO here unless Vlad wants it. What is to stop Vlad and co leaving and starting HEMO2 with all the knowledge and skills they possess. Take Vlad and Co out of HEMO you have nothing.
If Vlad and co leave the company you just bought, what have you actually bought?

No it does not.

Just doubled my holding to average down to 4.5, I fully plan to take out 1/2 if that is reached unless some meaty RNS changes my mind. Only time will tell.

@JHFH I agree with you, my comment was not aimed at you. It was aimed at bashing that you and others get for posts made many months ago as if you were supposed to know it was gong to unfold this way.

Circumstances and outlooks change as do the opinions with them. Why do people get nailed to the cross on an opinion they held from 6-12 months ago when HEMO look vastly different than it does now. No one knew the Lilly would be a no deal (for now) and lead us here with the CLN's.
As facts change so do opinions...get over it.

otherwise ORPH @34.5